Advertisement
| eml clinical guide: The Selection and Use of Essential Medicines WHO Expert Committee on the Selection and Use of Essential Medicines, 2004 This report presents the recommendations of the WHO Expert Committee responsible for updating the WHO Model List of Essential Medicines. The first part contains a progress report on the new procedures for updating the Model List and the development of the WHO Essential Medicines Library. It continues with a section on changes made in revising the Model List followed by a review of some sections such as hypertensive medicines and fast track procedures for deleting items. Annexes include the 13th version of the Model List and items on the list sorted according to their 5-level Anatomical Therapeutic Chemical classification codes. |
| eml clinical guide: Tietz Clinical Guide to Laboratory Tests - E-Book Alan H. B. Wu, 2006-06-08 This new edition of Norbert Tietz's classic handbook presents information on common tests as well as rare and highly specialized tests and procedures - including a summary of the utility and merit of each test. Biological variables that may affect test results are discussed, and a focus is placed on reference ranges, diagnostic information, clinical interpretation of laboratory data, interferences, and specimen types. New and updated content has been added in all areas, with over 100 new tests added. - Tests are divided into 8 main sections and arranged alphabetically. - Each test includes necessary information such as test name (or disorder) and method, specimens and special requirements, reference ranges, chemical interferences and in vivo effects, kinetic values, diagnostic information, factors influencing drug disposition, and clinical comments and remarks. - The most current and relevant tests are included; outdated tests have been eliminated. - Test index (with extensive cross references) and disease index provide the reader with an easy way to find necessary information - Four new sections in key areas (Preanalytical, Flow Cytometry, Pharmacogenomics, and Allergy) make this edition current and useful. - New editor Alan Wu, who specializes in Clinical Chemistry and Toxicology, brings a wealth of experience and expertise to this edition. - The Molecular Diagnostics section has been greatly expanded due to the increased prevalence of new molecular techniques being used in laboratories. - References are now found after each test, rather than at the end of each section, for easier access. |
| eml clinical guide: Drug Benefits and Risks C.J. van Boxtel, B. Santoso, I.R. Edwards, 2008-08-06 This updated and revised 2nd edition of Drug Benefits and Risks is an inclusive reference exploring the scientific basis and practice of drug therapy. The key concept is to look at the balance between the benefits and risks of drugs, but in this context also highlighting the social impact which drugs have in modern societies. Taking an evidence-based approach to the problem, the practice of clinical pharmacology and pharmacotherapy in the developing as well as the developed world is examined. For this purpose the book covers general clinical pharmacology, pharmacology of various drug groups and the treatments specific to various diseases; the book gives guidance on how doctors should act so that drugs can be used effectively and safely; and it encourages the rational use of drugs in society. This publication brings together a large amount of excellent content that will be invaluable for anyone working within, or associated with, the field of clinical pharmacology and pharmacotherapy - undergraduates, postgraduates, regulatory authorities and the pharmaceutical industry. |
| eml clinical guide: WHO normative function at the country level World Health Organization, 2024-07-10 The WHO Evaluation Office presents a comprehensive evaluation of the organization’s normative function at the country level. The evaluation sheds light on the impact and effectiveness of WHO's normative products within individual countries and offers valuable insights and recommendations. WHO's normative function is at the core of its mandate and constitution. To ensure its relevance and effectiveness, periodic assessments are crucial. Building upon a previous global evaluation conducted in 2017, this evaluation aims to understand and strengthen WHO's normative role at the country level. It aligns with WHO's commitment to prioritize countries in its work. |
| eml clinical guide: The Selection and Use of Essential Medicines World Health Organization, 2017 This report presents the recommendations of the WHO Expert Committee responsible for updating the WHO Model Lists of Essential Medicines. It contains a summary of the Committee's considerations and justifications for additions and changes to the Model Lists, including its recommendations. Annexes to the main report include the revised version of the WHO Model List of Essential Medicines (20th edition) and the WHO Model List of Essential Medicines for Children (6th edition). In addition there is a list of all the items on the Model Lists sorted according to their Anatomical Therapeutic Chemical (ATC) classification codes. |
| eml clinical guide: Guide to Paediatric Drug Development and Clinical Research Klaus Rose, John N. Van den Anker, 2010-01-01 Children in the developed world have never enjoyed better medical care: mortality has decreased and many fatal diseases of the past can today be prevented or even cured. However, the current practice of pharmacotherapy in children does not reflect existing scientific knowledge and has come under scrutiny by paediatricians, pharmacists and regulatory authorities. In order to advance the development of medicines tailored to paediatric needs, US and EU legislators have taken action, and the WHO has initiated a global paediatric campaign. This book gives an overview over the worldwide activities that increasingly include children in the development of new medicines. Triggered by both a better understanding of how the child's body develops as well as recent legislation in the USA and in Europe, this comprises dosing, ethics, age-appropriate pharmaceutical forms and clinical trials, to name just a few aspects.A wide spectrum of readers will profit from this book, including paediatricians, pharmacists, general practitioners and health care professionals involved in child care and paediatric research, clinical trial personnel, patient advocacy groups, ethics committees, politicians, parents and interested lay persons. |
| eml clinical guide: Clinical Manual of Blood and Bone Marrow Transplantation Syed A. Abutalib, Parameswaran Hari, 2017-04-19 Providing the practicing and trainee hematologist with a practical and immediately applicable compendium of answers the Clinical Manual of Blood and Bone Marrow Transplantation covers the spectrum of the hematopoietic cell transplant specialty, in particular practical issues in transplant patient care, and the set up and functioning of a transplant program. Supplies the practicing and trainee hematologist with a practical and immediately applicable compendium of answers to clinical questions Covers the spectrum of the hematopoietic cell transplant specialty, in particular practical issues in transplant patient care, and the set up and functioning of a transplant program Contains concise chapters written with a focus on tables, algorithms and figures to aid rapid referral Benefits from expert contributions from an international authorship |
| eml clinical guide: Managing Pharmaceuticals in International Health Stuart Anderson, Reinhard Huss, Rob Summers, Karin Wiedenmayer, 2012-12-06 One third of the world's population lack effective access to quality assured essential medicines used rationally. When WHO first made this statement fifteen years ago, there was general concern that medical miracles such as antibiotics, antiparasitic medicines, vaccines and anal gesics would not be available to many people. Today, the proportion of those lack ing access is lower in Asia and Latin America and higher in Africa but there are probably about two billion people in this situation. This book describes the many problems involved, and then puts together possible solutions based on country expe riences in a comprehensive and coherent manner. Many people lack access to essential medicines because they and their countries are poor, and because of inefficiencies in their health systems. We know that in low and middle income countries between 25 and 40 per cent of health expenditure is on medicines, and that most of that expenditure is out of pocket. Often this amounts to less than US $ 2 per head per year! In contrast, high income countries spend only 8 to 15 per cent of health expenditure on medicines, and this is mostly paid for by health insurance or social security funds. High income country expen diture may be over US $ 400 per person per year! So managing the scanty resources available in low income countries becomes all the more important. |
| eml clinical guide: Handbook of Evidence-based Psychotherapies Chris Freeman, Mick Power, 2007-03-13 At a time when evidence is everything, the comprehensive Handbook of Evidence-Based Psychotherapies handbook provides a unique, up-to-date overview of the current evidence-base for psychological therapies and major psychological disorders. The editors take a pluralistic approach, covering cognitive and behavioural therapies as well as counselling and humanistic approaches. Internationally-renowned expert contributors guide readers through the latest research, taking a critical overview of each practice’s strengths and weaknesses. A final chapter provides an overview for the future. |
| eml clinical guide: The Use of Essential Drugs World Health Organization, 1990 |
| eml clinical guide: The Selection and Use of Essential Medicines Organisation mondiale de la santé. Comité d'experts de la sélection et l'utilisation des médicaments essentiels. Réunion, World Health Organization, 2015 This report presents the recommendations of the WHO Expert Committee responsible for updating the WHO Model Lists of Essential Medicines.. The goal of the meeting was to review and update the 18th WHO Model List of Essential Medicines (EML) and the 4th WHO Model List of Essential Medicines for Children (EMLc). In accordance with approved procedures, the Expert Committee evaluated the scientific evidence on the basis of the comparative effectiveness, safety and cost effectiveness of the medicines. Both lists went through major revisions this year, as the Committee considered 77 applications, including 29 treatment regimens for cancer, and innovative hepatitis C and tuberculosis (TB) medicines. The Expert Committee recommended the addition of 36 new medicines to the EML (15 to the core list and 21 to the complementary list); and recommended the addition of 16 new medicines to the EMLc (five to the core list and 11 to the complementary list). Annexes to the main report include the revised version of the WHO Model List of Essential Medicines (19th edition) and the WHO Model List of Essential Medicines for Children (5th edition). In addition there is a list of all the items on the Model List sorted according to their Anatomical Therapeutic Chemical (ATC) classification codes. |
| eml clinical guide: Noncommunicable Diseases Nick Banatvala, Pascal Bovet, 2023-01-30 Noncommunicable Diseases: A Compendium introduces readers to noncommunicable diseases (NCDs) – what they are, their burden, their determinants and how they can be prevented and controlled. Focusing on cardiovascular disease, diabetes, cancer and chronic respiratory disease and their five shared main risk factors (tobacco use, harmful use of alcohol, unhealthy diet, physical inactivity and air pollution) as defined by the United Nations, this book provides a synopsis of one of the world’s biggest challenges of the 21st century. NCDs prematurely claim the lives of millions of people across the world every year, with untold suffering to hundreds of millions more, trapping many people in poverty and curtailing economic growth and sustainable development. While resources between and within countries largely differ, the key principles of surveillance, prevention and management apply to all countries, as does the need to focus resources on the most cost-effective and affordable interventions and the need for strong political will, sufficient resources, and sustained and broad partnerships. This compendium consists of 59 short and accessible chapters in six sections: (i) describing and measuring the burden and impact of NCDs; (ii) the burden, epidemiology and priority interventions for individual NCDs; (iii) social determinants and risk factors for NCDs and priority interventions; (iv) global policy; (v) cross-cutting issues; and (vi) stakeholder action. Drawing on the expertise of a large and diverse team of internationally renowned policy and academic experts, the book describes the key epidemiologic features of NCDs and evidence-based interventions in a concise manner that will be useful for policymakers across all parts of society, as well as for public health and clinical practitioners. The Open Access version of this book, available at http://www.taylorfrancis.com, has been made available under a Creative Commons Attribution-Non Commercial-No Derivatives (CC-BY-NC-ND) 4.0 license. |
| eml clinical guide: Indicators for Monitoring National Drug Policies Pascale Brudon, Jean-Daniel Rainhorn, Michael R. Reich, World Health Organisation Staff, World Health Organization, 2000-08-30 All countries have a pharmaceutical policy of some sort. They want make effective, safe, low cost drugs available and they want to ensure that the drugs are of good quality and used rationally. However there is a need for tools to evaluate the performance of the pharmaceutical sector or monitor the implementation of a national drugs policy. This manual shows the indicators to be used. It is aimed at mangers responsible for drug policies, policy makers and international agencies' experts. |
| eml clinical guide: Promoting Access to Medical Technologies and Innovation - Intersections between Public Health, Intellectual Property and Trade World Intellectual Property Organization, 2013 This study has emerged from an ongoing program of trilateral cooperation between WHO, WTO and WIPO. It responds to an increasing demand, particularly in developing countries, for strengthened capacity for informed policy-making in areas of intersection between health, trade and IP, focusing on access to and innovation of medicines and other medical technologies. |
| eml clinical guide: WHO guideline on country pharmaceutical pricing policies , 2020-09-29 In recent years, high prices of pharmaceutical products have posed challenges in high- and low-income countries alike. In many instances, high prices of pharmaceutical products have led to significant financial hardship for individuals and negatively impacted on healthcare systems' ability to provide population-wide access to essential medicines. Pharmaceutical pricing policies need to be carefully planned, carried out, and regularly checked and revised according to changing conditions. Strong, well-thought-out policies can guide well-informed and balanced decisions to achieve affordable access to essential health products. This guideline replaces the 2015 WHO guideline on country pharmaceutical pricing policies, revised to reflect the growing body of literature since the last evidence review in 2010. This update also recognizes country experiences in managing the prices of pharmaceutical products. |
| eml clinical guide: Multiple first-line therapies as part of the response to antimalarial drug resistance World Health Organization, 2024-11-20 Effective malaria case management requires quick access to diagnostics and antimalarial treatments to reduce illness and death. Artemisinin-based combination therapy (ACT) has been essential to malaria treatment since 2001, as it combines artemisinin for rapid parasite reduction with a partner drug to ensure complete cure. However, resistance to antimalarial drugs, where parasites survive standard doses, threatens malaria control. Partial resistance to artemisinin, linked to Pfkelch13 mutations, has recently emerged in several African countries, leading to slower parasite clearance times. Artemisinin partial resistance does not lead to ACT failure where the partner medicines are still effective. However, additional resistance to partner drugs would jeopardize ACT effectiveness. To address this threat, WHO launched a 2022 strategy to respond to drug resistance in Africa. This strategy aims to improve detection, enable timely responses, and reduce resistance impact through evidence-based measures. The strategy with 20 approaches includes the measures such as multiple first-line therapies (MFT) to extent the therapeutic useful life of the ACTs. This implementation guide providing guidance for malaria programmes by defining MFT, reviewing MFT’s impact on resistance, assessing implications for policy and implementation and identifying evidence gaps for future research. |
| eml clinical guide: Tietz Clinical Guide to Laboratory Tests Alan H. B. Wu, 2006 Dr. Tietz is retiring his involvement with this publication, and his r eplacement is Dr. Richard McPherson, Chairman of the Department of Pat hology at the Medical College of Virginia. He is very well-respected, serves on the board of CAP, and runs one of the largest university ref erence libraries in the nation. the fourth edition maintains the same overall organization and content that has been so useful to clinical u sers in the past three editions. |
| eml clinical guide: Primary Clinical Care Manual Lucy Wagstaff, 2019-07-04 A comprehensive practical reference guide for medical, nursing, and para-medical personnel that sets out guidelines for the diagnosis and management of primary clinical conditions. |
| eml clinical guide: Revising the procedures for updating WHO’s Model Lists of Essential Medicines World Health Organization, 2024-04-16 First published in 1977 and updated every two years, the WHO Model List of Essential Medicine serves as a guide for countries or regional authorities to adopt or adapt in accordance with local priorities and treatment guidelines for the development and updating of national and institutional essential medicine lists. It is a key tool for achieving UHC because it supports governments, health facilities, and procurers in identifying which medicines are the best options in terms of benefits for individuals and communities. The current procedure for updating the WHO Model List of Essential Medicines was established in 2001. This represents the only major revision to the EML selection process since the first Model List was published in 1977. A consultation meeting for revising procedures for updating the WHO Model List of Essential Medicines was convened by WHO at its headquarters in Geneva on 2-3 November 2023. Discussions traced the EML’s evolution since 1977, underscoring its ongoing role in enabling universal health coverage despite the pricing and feasibility barriers posed by new innovative treatments. Successes were noted in expanding global availability of antibiotics, cancer therapies, and other essential medicines such as antivirals against hepatitis C. Nevertheless, delays in access due to price barriers persist, and feasibility issues are emerging such as diagnosis of complex diseases, highlighting opportunities to refine evidence-based selection processes. |
| eml clinical guide: Handbook of Palliative Care Richard Kitchen, Christina Faull, Sarah Russell, Jo Wilson, 2024-05-08 Handbook of palliative care Comprehensive resource utilising up-to-date evidence and guidelines to support non-specialists in palliative care in both hospital and community settings Building on the success of previous editions, this new edition of the award winning handbook has a practical focus and provides the user with an approach to clinical challenges while also providing enough information to explain why this approach is suggested. The 4th edition of Handbook of Palliative Care supports non-specialists in palliative care in both hospital and community settings and focuses on holistic care and therapeutic interventions. With several new chapters and content significantly updated to reflect new evidence and practice, the 4th edition also presents up-to-date evidence, guidance in a succinct format and utilises flow charts and figures to enhance the accessibility of information. Written by four highly accomplished nursing and medical authors with over 100 years’ experience between them in hospital, hospice, care home and community settings, Handbook of Palliative Care provides: Guidance from clinicians who are experts in their field An acknowledgment of the requirements of healthcare professionals attending to patients with palliative care needs, along with a dedicated chapter addressing this topic Contemporary guidance on medicine management, symptom control and managing complications of cancer Palliative care in heart failure, renal disease and advanced liver, neurological and respiratory diseases An in-depth look at patient and public involvement in palliative care and inequity Skill development including communication, ethical considerations and spiritual care New chapters including frailty, dementia, and multi-morbidity; and palliative care for people living with mental illness and people with intellectual disabilities This 4th edition of Handbook of Palliative Care is an ideal supporting resource for doctors, nurses and other healthcare professionals caring for patients with palliative care needs in the UK and beyond. The 1st edition was the winner of the 1999 BMA Medical Book of the Year Prize. |
| eml clinical guide: Technical Report Series , 1950 |
| eml clinical guide: Nurse as Educator Susan B. Bastable, 2007-12-12 Nurse as Educator: Principles of Teaching and Learning for Nursing Practice prepares nurse educators, clinical nurse specialists, and nurse practitioners for their ever-increasing roles in patient teaching, health education, health promotion, and nursing education. Designed to teach nurses about the development, motivational, and sociocultural differences that affect teaching and learning, this text combines theoretical and pragmatic content in a balanced, complete style. The Third Edition of this best-selling text has been updated and revised to include the latest research. Nurse as Educator is used extensively in nursing educations courses and programs, as well as in both institutional and community-based settings. |
| eml clinical guide: Rickettsial Diseases Didier Raoult, Philippe Parola, 2007-04-26 The only available reference to comprehensively discuss the common and unusual types of rickettsiosis in over twenty years, this book will offer the reader a full review on the bacteriology, transmission, and pathophysiology of these conditions. Written from experts in the field from Europe, USA, Africa, and Asia, specialists analyze specific patho |
| eml clinical guide: The selection and use of essential in vitro diagnostics , 2021-01-29 |
| eml clinical guide: Handbook of Clinical Audiology Jack Katz, Wilma Laufer Gabbay, 1994 Containing broad coverage of clinical audiology in areas of both diagnosis and rehabilitation, this work includes information on the nature of auditory disorders, peripheral and auditory functions and physiological evaluation of the auditory system. Over 60 contributors present historical and thheoretical, practical information on an array of topics in audiology. As well as giving information regarding sensory aids and communication training, the text covers special populations and management of auditory problems. |
| eml clinical guide: Evidence-based Rehabilitation Mary C. Law, Joy MacDermid, 2008 Evidence-Based Rehabilitation: A Guide to Practice, Second Edition is an essential resource for students and practitioners to help incorporate the most current and complete evidence-based research into rehabilitation practice.--BOOK JACKET. |
| eml clinical guide: Buddha's Brain Rick Hanson, 2025-03-01 Change your brain, change your life with this essential classic from New York Times bestselling author, Rick Hanson—now celebrating 15 years in print with more than 500,000 copies sold! Great teachers like the Buddha, Jesus, Moses, Mohammed, and Gandhi were all born with brains built essentially like anyone else’s—and then they changed their brains in ways that changed the world. Neuroscience now reveals how the flow of thoughts actually sculpt the brain, and more and more, we are learning that it’s possible to strengthen positive brain states. By combining breakthroughs in science with insights from thousands of years of mindfulness practice, you too can shape your own “Buddha’s Brain” for greater happiness, love, and wisdom. Buddha’s Brain draws on evidence-based neuroscience to show you how to stimulate your brain for more fulfilling relationships, a deeper spiritual life, and a greater sense of inner confidence and self-worth. Using guided meditations and mindfulness exercises, you’ll learn how to activate the brain states of calm, joy, and compassion instead of worry, sorrow, and anger. Most importantly, you will foster positive psychological growth that will literally change the way you live in your day-to-day life. This book provides an essential intersection of psychology, neurology, and contemplative practice, and is filled with practical tools and skills that you can use every day to tap into the unused potential of your brain and rewire it over time for greater well-being. |
| eml clinical guide: WHO Model Prescribing Information World Health Organization, 2001 This book provides independent clinical information on essential drugs, including details of dosage, uses, contraindications and adverse effects. It is intended as source material for adaptation by national authorities, in particular developing countries, that which to produce drug formularies, data sheets and teaching materials. |
| eml clinical guide: Silenced Angels James Peinkofer, 2002-01-30 Silenced Angels: The Medical, Legal and Social Aspects of Shaken Baby Syndrome delves into the realms of child abuse that has never been explored before in such detail. The book examines how the physical assault of violent shaking on a young body can lead to a lifetime of despair or even death. Every important detail of this tragic form of child abuse is analyzed, providing the reader a more definitive understanding of the condition known as SBS. This is the first book written exclusively about SBS, which is 100% preventable. SBS cases can be frequently misdiagnosed and are more frequently under-investigated and poorly prosecuted, leading to a sense of injustice among families and child abuse prevention advocates. The author breaks through the barriers of miscomprehension, misdiagnosis, and misrepresentation that typically lead to further tragedy and injustice in SBS-related cases. Advocates for child abuse prevention will gain greater information about SBS to further their cause of establishing hospital and community-based prevention and education programs. Parents and family members of SBS victims will find this book indispensable when seeking medical and legal assistance with their cases. |
| eml clinical guide: Conflict of Interest in Medical Research, Education, and Practice Institute of Medicine, Board on Health Sciences Policy, Committee on Conflict of Interest in Medical Research, Education, and Practice, 2009-10-16 Collaborations of physicians and researchers with industry can provide valuable benefits to society, particularly in the translation of basic scientific discoveries to new therapies and products. Recent reports and news stories have, however, documented disturbing examples of relationships and practices that put at risk the integrity of medical research, the objectivity of professional education, the quality of patient care, the soundness of clinical practice guidelines, and the public's trust in medicine. Conflict of Interest in Medical Research, Education, and Practice provides a comprehensive look at conflict of interest in medicine. It offers principles to inform the design of policies to identify, limit, and manage conflicts of interest without damaging constructive collaboration with industry. It calls for both short-term actions and long-term commitments by institutions and individuals, including leaders of academic medical centers, professional societies, patient advocacy groups, government agencies, and drug, device, and pharmaceutical companies. Failure of the medical community to take convincing action on conflicts of interest invites additional legislative or regulatory measures that may be overly broad or unduly burdensome. Conflict of Interest in Medical Research, Education, and Practice makes several recommendations for strengthening conflict of interest policies and curbing relationships that create risks with little benefit. The book will serve as an invaluable resource for individuals and organizations committed to high ethical standards in all realms of medicine. |
| eml clinical guide: Pediatric Clinical Pharmacology Hannsjörg W. Seyberth, Anders Rane, Matthias Schwab, 2011-09-01 The objective of this volume is to give an overview of the present state of the art of pediatric clinical pharmacology including developmental physiology, pediatric-specific pathology, special tools and methods for development of drugs for children (assessment of efficacy, toxicity, long-term safety etc.) as well as regulatory and ethical knowledge and skills. In the future, structural and educational changes have to lead back to a closer cooperation and interaction of pediatrics with (clinical) pharmacology and pharmacy. |
| eml clinical guide: Manual of Childhood Infections Mike Sharland, Andrew Cant, E. Graham Davies, David A. C. Elliman, Susanna Esposito, Delane Shingadia, Adam Finn, 2011-04-07 This manual gives information on the causative organisms, epidemiology and clinical features of all important childhood infections. It includes guidance on the clinical management of the infections and on steps to be taken to prevent future cases. |
| eml clinical guide: WHO fungal priority pathogens list to guide research, development and public health action World Health Organization, 2022-10-25 |
| eml clinical guide: WHO Expert Committee on Biological Standardization , 2021-05-06 The seventy-second meeting of the WHO Expert Committee on Biological Standardization was held from 19 to 23 October 2020 by WebEx video conferencing due to the restrictions imposed during the coronavirus disease 2019 (COVID-19) pandemic. The meeting was opened on behalf of the Director-General of WHO by Dr Mariângela Batista Galvão Simão, Assistant Director-General, Access to Medicines and Health Products. Dr Simão welcomed Committee members, meeting participants and observers. Dr Simão began by noting that the Committee had met as recently as August 2020, primarily to address standardization activities related to COVID-19, and that much remains to be learnt about the pandemic. The WHO Solidarity Trial was continuing to facilitate the rapid and robust comparison of potential treatments. Recently published interim results indicated that the four small molecule treatments remdesivir, hydroxychloroquine, lopinavir/ritonavir and interferon had little or no benefit in terms of overall mortality or speed of recovery of hospitalized patients – to date only dexamethasone had proved to be effective against severe COVID-19. |
| eml clinical guide: Prescribing Medicines for Children Mike Sharland, 2019-07-17 Prescribing for children is a particularly challenging discipline due to specific issues of drug absorption, metabolism, distribution and excretion. The aim of this book is to improve understanding in all aspects of paediatric prescribing, from the development of suitable drugs through to their practical administration. With its origins in the EU-funded Global Research in Paediatrics (GRiP) project this is the first truly international textbook to provide guidance on the principles behind optimal neonatal and paediatric prescribing. Harnessing the international expertise of paediatricians and pharmacists in the field, Prescribing Medicines for Children compliments the British National Formulary for Children (BNFC), facilitating translation of essential pharmacological principles into good prescribing practice. It incorporates specific information on how to promote safe and effective prescribing in paediatrics, including how to avoid medication errors and adverse drug reactions in children. Highlights include the differences in prescribing habits between countries and the shared principles that underpin rational prescribing in paediatrics and neonatology. The book is divided into two sections: Section A provides concise educational material relating to paediatric pharmacology and optimising how medicines are developed and prescribed for children. Section B considers key clinical prescribing areas and can be used as a quick reference guide. Each chapter is focused on the key issues in prescribing for a respective clinical specialty or context. Prescribing Medicines for Children is essential reading for all those who are involved in prescribing medicines to neonates and children. This includes undergraduate and postgraduate pharmacists, nurses, paediatricians and primary care physicians, academic scientists, and those working in the pharmaceutical industry and drug regulation. |
| eml clinical guide: Medical Management of Abortion World Health Organization, 2019-01-30 Medical abortion care encompasses the management of various clinical conditions including spontaneous and induced abortion (both viable and non-viable pregnancies) incomplete abortion and intrauterine fetal demise as well as post-abortion contraception. Medical management of abortion generally involves either a combination regimen of mifepristone and misoprostol or a misoprostol-only regimen. Medical abortion care plays a crucial role in providing access to safe effective and acceptable abortion care. In both high- and low-resource settings the use of medical methods of abortion have contributed to task shifting and sharing and more efficient use of resources. Moreover many interventions in medical abortion care particularly those in early pregnancy can now be provided at the primary-care level and on an outpatient basis which further increases access to care. Medical abortion care reduces the need for skilled surgical abortion providers and offers a non-invasive and highly acceptable option to pregnant individuals. |
| eml clinical guide: Disease Control Priorities, Third Edition (Volume 4) Vikram Patel, Dan Chisholm, Tarun Dua, Ramanan Laxminarayan, Mari'a Lena Medina-Mora, Theo Vos, 2016-03-10 Mental, neurological, and substance use disorders are common, highly disabling, and associated with significant premature mortality. The impact of these disorders on the social and economic well-being of individuals, families, and societies is large, growing, and underestimated. Despite this burden, these disorders have been systematically neglected, particularly in low- and middle-income countries, with pitifully small contributions to scaling up cost-effective prevention and treatment strategies. Systematically compiling the substantial existing knowledge to address this inequity is the central goal of this volume. This evidence-base can help policy makers in resource-constrained settings as they prioritize programs and interventions to address these disorders. |
| eml clinical guide: Clinical Pharmacy Education, Practice and Research Dixon Thomas, 2018-11-23 Clinical Pharmacy Education, Practice and Research offers readers a solid foundation in clinical pharmacy and related sciences through contributions by 83 leading experts in the field from 25 countries. This book stresses educational approaches that empower pharmacists with patient care and research competencies. The learning objectives and writing style of the book focus on clarifying the concepts comprehensively for a pharmacist, from regular patient counseling to pharmacogenomics practice. It covers all interesting topics a pharmacist should know. This book serves as a basis to standardize and coordinate learning to practice, explaining basics and using self-learning strategies through online resources or other advanced texts. With an educational approach, it guides pharmacy students and pharmacists to learn quickly and apply. Clinical Pharmacy Education, Practice and Research provides an essential foundation for pharmacy students and pharmacists globally. - Covers the core information needed for pharmacy practice courses - Includes multiple case studies and practical situations with 70% focused on practical clinical pharmacology knowledge - Designed for educational settings, but also useful as a refresher for advanced students and researchers |
| eml clinical guide: Essentials of Global Mental Health Samuel O. Okpaku, 2014-02-27 Defines an approach to mental healthcare focused on achieving international equity in coverage, options and outcomes. |
| eml clinical guide: Managing Pain in Children and Young People Alison Twycross, Jennifer Stinson, William Zempsky, Abbie Jordan, 2024-06-04 Master paediatric pain management with precision This practical guide equips nurses and healthcare professionals with evidence-based skills to effectively manage children's pain. Explore assessment techniques, pain relief strategies, and best practices for both hospital and community settings, with a focus on core knowledge, advanced insights, clinical scenarios, and practical tips. The fully updated third edition includes an expanded procedural sedation section, enhanced coverage of capnography for respiratory monitoring, a new quality improvement sciences section, and additional online MCQs and self-assessment material. Written by experienced authors, with contributions from global experts, Managing Pain in Children and Young People covers: Why pain prevention and treatment are crucial Pain's biopsychosocial nature and pharmacology of analgesic drugs Acute nociceptive, neuropathic, and visceral pain management Chronic headaches, post-surgical pain, neonatal pain, and procedural pain Paediatric palliative care and pain management in low-income countries Drug-free pain relief methods and ethical considerations With a multidisciplinary focus, this essential resource is tailored for healthcare practitioners working with children and young people; including doctors, nurses, psychologists, and physiotherapists. This essential resource empowers you to provide the best possible care for young patients, helping them find comfort and relief in their journey towards healing. |
Viewing ( Electronic Mail Format) EML files in Windows 11 or 10
Jun 29, 2022 · b. Use free desktop software to view EML files offline . The second method to view EML files on Windows PC is to use a free desktop application. Here are the free software to …
Save EML file - Microsoft Community
4 days ago · Remember, the EML file format is a standard format used by many email clients, so once saved, you can open it with different programs, not just Outlook. Remember to keep your …
The new Outlook app doesn't open .eml files - Microsoft Community
Sep 28, 2023 · Hello, recently the new Outlook app replaced the Mail and Calendar apps. It's nice, but I noticed that when I double click on a .eml file (that was usually opened with the Mail …
how to import eml files - Microsoft Community
Mar 18, 2024 · First, open Outlook and create a new folder where you want the *.eml files to be stored. Then, simply drag and drop your *.eml files into this folder. Second, once you have all …
MSG vs EML - Microsoft Community
Nov 20, 2013 · Outlook can read *.eml file, however the email messages can be only saved in *.msg format. If you intend to save the entire Outlook data, I suggest you to archive/backup the …
How to open .eml files in Windows 7? - Microsoft Community
Jul 28, 2010 · Original title: Opening eml files stored in My Documents. I recently changed my desktop computer from one using Windows XP to one using Windows 7. I transferred from my …
Outlook - Unable to preview or save .eml attachments
Nov 26, 2024 · I cannot preview or download incoming attached email (.eml) threads. The only option is to download the file - when I do the filetype is just "File". I can only view and download …
How to mark .eml safe or change the drag and drop file to my …
Jun 14, 2024 · Select a .eml, .msg, or .oft file. Drag and drop the file onto the reading pane area. You can also right-click or double-click the .eml, .msg, or .oft file to open them in new Outlook. …
Can I import .eml files into Outlook 365 - Microsoft Community
Nov 28, 2019 · Create a folder in Outlook desktop - then open the folder with the eml files, select all and drag to the new folder. If it errors, try dragging 50 at a time instead. -- Diane Poremsky …
eml格式的邮件怎么导入到Outlook中去 - Microsoft Community
Sep 29, 2024 · 了解到您对 .eml 格式邮件怎么导入Outlook存在疑问，我很乐意替您解答。 首先想确认，您使用的是新版Outlook吗？ 可以使用拖放功能打开使用 新版 Outlook 中的扩展名 .eml …
Viewing ( Electronic Mail Format) EML files in Windows 11 or 10
Jun 29, 2022 · b. Use free desktop software to view EML files offline . The second method to view EML files on Windows PC is to use a free desktop application. Here are the free software to …
Save EML file - Microsoft Community
4 days ago · Remember, the EML file format is a standard format used by many email clients, so once saved, you can open it with different programs, not just Outlook. Remember to keep your …
The new Outlook app doesn't open .eml files - Microsoft Community
Sep 28, 2023 · Hello, recently the new Outlook app replaced the Mail and Calendar apps. It's nice, but I noticed that when I double click on a .eml file (that was usually opened with the Mail …
how to import eml files - Microsoft Community
Mar 18, 2024 · First, open Outlook and create a new folder where you want the *.eml files to be stored. Then, simply drag and drop your *.eml files into this folder. Second, once you have all …
MSG vs EML - Microsoft Community
Nov 20, 2013 · Outlook can read *.eml file, however the email messages can be only saved in *.msg format. If you intend to save the entire Outlook data, I suggest you to archive/backup the …
How to open .eml files in Windows 7? - Microsoft Community
Jul 28, 2010 · Original title: Opening eml files stored in My Documents. I recently changed my desktop computer from one using Windows XP to one using Windows 7. I transferred from my …
Outlook - Unable to preview or save .eml attachments
Nov 26, 2024 · I cannot preview or download incoming attached email (.eml) threads. The only option is to download the file - when I do the filetype is just "File". I can only view and …
How to mark .eml safe or change the drag and drop file to my …
Jun 14, 2024 · Select a .eml, .msg, or .oft file. Drag and drop the file onto the reading pane area. You can also right-click or double-click the .eml, .msg, or .oft file to open them in new Outlook. …
Can I import .eml files into Outlook 365 - Microsoft Community
Nov 28, 2019 · Create a folder in Outlook desktop - then open the folder with the eml files, select all and drag to the new folder. If it errors, try dragging 50 at a time instead. -- Diane Poremsky …
eml格式的邮件怎么导入到Outlook中去 - Microsoft Community
Sep 29, 2024 · 了解到您对 .eml 格式邮件怎么导入Outlook存在疑问，我很乐意替您解答。 首先想确认，您使用的是新版Outlook吗？ 可以使用拖放功能打开使用 新版 Outlook 中的扩展名 .eml …
